26 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18585339 | GLP-1 RECEPTOR LIGAND MOIETY CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF | BEANE, RANDALL L | 1654 | Final Rejection | Feb 23, 2024 |
| 18548711 | PURIFICATION METHODS FOR OLIGOMERIC COMPOUNDS | KRISHNAN, GANAPATHY | 1693 | Non-Final OA | Sep 01, 2023 |
| 18546462 | COMPOUNDS AND METHODS FOR REDUCING NLRP3 EXPRESSION | CHONG, KIMBERLY | 1636 | Non-Final OA | Aug 15, 2023 |
| 18263194 | COMPOUNDS AND METHODS FOR MODULATING HUNTINGTIN | TATGE, LEXUS MARC | 1637 | Non-Final OA | Jul 27, 2023 |
| 18262438 | COMPOUNDS AND METHODS FOR REDUCING DUX4 EXPRESSION | KONOPKA, CATHERINE ANNE | 1635 | Non-Final OA | Jul 21, 2023 |
| 18247567 | METHODS FOR REDUCING APOCIII EXPRESSION | POLIAKOVA-GEORGAN, EKATERINA | 1637 | Non-Final OA | Mar 31, 2023 |
| 18158290 | COMPOSITIONS AND METHODS FOR MODULATING PKK EXPRESSION | MCGARRY, SEAN | 1635 | Non-Final OA | Jan 23, 2023 |
| 18001848 | COMPOUNDS AND METHODS FOR MODULATING PMP22 | POLIAKOVA-GEORGAN, EKATERINA | 1637 | Final Rejection | Dec 14, 2022 |
| 18001241 | COMPOUNDS AND METHODS FOR REDUCING MSH3 EXPRESSION | SHIN, DANA H | 1635 | Non-Final OA | Dec 08, 2022 |
| 17998141 | CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF | ROSSI, JULIA ANNE LORRAIN | 1615 | Non-Final OA | Nov 07, 2022 |
| 17802324 | COMPOUNDS AND METHODS FOR MODULATING SCN1A EXPRESSION | POLIAKOVA-GEORGAN, EKATERINA | 1637 | Non-Final OA | Aug 25, 2022 |
| 17800785 | METHODS FOR REDUCING HTT EXPRESSION | CHONG, KIMBERLY | 1636 | Non-Final OA | Aug 18, 2022 |
| 17721765 | Compositions for Modulating C9ORF72 Expression | PERSONS, JENNA L | 1637 | Final Rejection | Apr 15, 2022 |
| 17611765 | SYNTHESIS OF OLIGOMERIC COMPOUNDS COMPRISING PHOSPHOROTHIOATE DIESTER AND PHOSPHODIESTER LINKAGES | LEE, HOI YAN NMN | 1693 | Final Rejection | Nov 16, 2021 |
| 17611780 | ANGIOTENSIN II TYPE 1 RECEPTOR TARGETED OLIGONUCLEOTIDES AND USES THEREOF | ARIETI, RUTH SOPHIA | 1635 | Final Rejection | Nov 16, 2021 |
| 17522594 | COMPOUNDS AND METHODS FOR REDUCING SNCA EXPRESSION | MCLEOD, AFRICA MHAIRIE | 1635 | Non-Final OA | Nov 09, 2021 |
| 17481679 | COMPOSITIONS AND METHODS FOR MODULATING TAU EXPRESSION | MCGARRY, SEAN | 1635 | Non-Final OA | Sep 22, 2021 |
| 17432237 | COMPOUNDS AND METHODS FOR REDUCING ATXN3 EXPRESSION | VANHORN, ABIGAIL LOUISE | 1636 | Final Rejection | Aug 19, 2021 |
| 17389599 | MODULATION OF HEPATITIS B VIRUS (HBV) EXPRESSION | ARIETI, RUTH SOPHIA | 1635 | Final Rejection | Jul 30, 2021 |
| 17424672 | COMPOUNDS AND METHODS FOR REDUCING APP EXPRESSION | PERSONS, JENNA L | 1637 | Final Rejection | Jul 21, 2021 |
| 17372173 | MODULATION OF APOLIPOPROTEIN C-III (APOCIII) EXPRESSION IN LIPOPROTEIN LIPASE DEFICIENT (LPLD) POPULATIONS | POLIAKOVA-GEORGAN, EKATERINA | 1637 | Final Rejection | Jul 09, 2021 |
| 17365307 | OLIGOMER-CONJUGATE COMPLEXES AND THEIR USE | TRAN, CHRISTINA L | 1637 | Final Rejection | Jul 01, 2021 |
| 17416108 | MODULATORS OF HSD17B13 EXPRESSION | ANGELL, JON E | 1637 | Final Rejection | Jun 18, 2021 |
| 17291199 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING AMYOTROPHIC LATERAL SCLEROSIS | QIAN, CELINE X | 1637 | Non-Final OA | May 04, 2021 |
| 16951449 | Compounds and Methods for Modulation of Transcript Processing | VYAS, KEYUR ANILKUMAR | 1637 | Final Rejection | Nov 18, 2020 |
| 16948435 | Compositions for Modulating C9ORF72 Expression | ANGELL, JON E | 1637 | Non-Final OA | Sep 18, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial